Global Substance Registration System
National Center For Advancing Translational Sciences
Investigators
Linked publications, trials & patents
Abstract
Globalization presents tremendous challenges and opportunities for national regulatory agencies, the pharmaceutical industry and global health. Emerging diseases and the health effects of catastrophic events respect no national boundaries, nor does the increasing volume of substandard, contaminated and count for pharmaceutical ingredients, counterfeit products that overburdens national regulators. Ingredients for pharmaceutical products are typically sourced on a global basis, and it is rare that all ingredients for a single product are produced within one jurisdiction. To regulate the global supply chain efficiently and better respond to and prepare for catastrophic events, it is essential to have a global information system. GSRS (Global Substance Registration System) is a registration system for the ingredients in medicinal products. This project, developed by NCATS scientists, makes it easier for regulators at FDA and other stakeholders to exchange information about substances in medicines, supporting regulatory oversight and scientific research on the use and safety of medicines. Major release GSRS 3.0 included a complete redesign of the backend to an extensible microservice architecture based on Spring Boot and Hibernate. Maintenance releases GSRS 3.0.1 and 3.02 include improved search syntax, performance enhancements, support for names using a UTF8 character set and added an advanced search facility. Behind the scenes, the flexible chemical library, Molwitch and Angular front end libraries were updated, and Java 11 is now supported..
View original record on NIH RePORTER →